Large gap with delayed quotes
|
Last quote
07/03/2025
-
20:20:00
|
Bid
07/03/2025 -
18:59:59
|
Bid Volume |
Ask
07/03/2025 -
18:59:59
|
Ask Volume |
|---|---|---|---|---|
|
129.19
+1.50
(
+1.17% )
|
128.88
|
400 |
129.19
|
900 |
Analysis date: 01.07.2025
Global Evaluation
Slightly negative
Slightly negative
The stock is classified in the slightly negative zone since 09.05.2025.
Interest
Weak
Weak
Two stars since 20.06.2025.
Earnings Rev Trend
Positive
Positive
Compared to seven weeks ago, the analysts have raised their earnings per share estimates. This positive trend began 25.03.2025 at a price of 70.79.
Evaluation
Overvalued
Overvalued
Based on its growth potential and our own criteria, we believe the share price is currently moderately overvalued.
MT Tech Trend
Positive
Positive
The forty day technical trend is positive since 25.03.2025.
4wk Rel Perf
0.56%
0.56%
The four-week dividend-adjusted performance versus SP500 is .
Sensibility
High
High
The stock has been on the high-sensitivity level since 04.02.2025.
Bear Market Factor
Low
Low
On average, the stock has a tendency to minimize the drops in the index by -0.57%.
Bad News Factor
Low
Low
When the stock's pressure is specific, the market sanction on average is 5.96%.
Mkt Cap in $bn
4.53
4.53
With a market capitalization between $2 & $8bn, TRANSMEDICS GROUP is considered a mid-cap stock.
G/PE Ratio
1.08
1.08
A ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) higher than 0.9 indicates that the stock's price presents a discount to growth of
LT P/E
35.44
35.44
The estimated PE is for the year 2027.
LT Growth
38.36%
38.36%
The annualized growth estimate is for the current year to 2027.
Avg. Nb analysts
9
9
Over the last seven weeks, an average of 9 analysts provided earnings per share estimates.
Dividend Yield
0.00%
0.00%
The company is not paying a dividend.
Beta
103
103
For 1% of index variation, the stock varies on average by 1.03%.
Correlation
0.30
0.30
Stock movements are strongly independent of index variations.
Value at Risk
79.61
79.61
The value at risk is estimated at USD 79.61. The risk is therefore 61.20%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
04.02.2025
04.02.2025